EyeWise DiagnosticsEyeWise Diagnostics
ED

EyeWise Diagnostics

Develops technology for early detection and tracking of diseases like Alzheimer's and AMD through non-invasive eye exams.

Website
2017Inactive6
Advertise here

About

EyeWise Diagnostics is developing a novel technology for the early detection and tracking of neurodegenerative and cardiovascular diseases. Their non-invasive eye examination device aims to identify early signs of conditions such as Alzheimer's Disease (AD), Age-related Macular Degeneration (AMD), Computer Vision Syndrome (CVS), and CardioVascular Disease.

Technology stack

detected 2026-05-24
Est. monthly stack spend~$40/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does EyeWise Diagnostics do?

EyeWise Diagnostics is developing a novel technology for the early detection and tracking of neurodegenerative and cardiovascular diseases. Their non-invasive eye examination device aims to identify early signs of conditions such as Alzheimer's Disease (AD), Age-related Macular Degeneration (AMD), Computer Vision Syndrome (CVS), and CardioVascular Disease.

How much funding has EyeWise Diagnostics raised?

EyeWise Diagnostics has raised a total of $1M in funding. The most recent round on record is Seed.

Where is EyeWise Diagnostics headquartered?

EyeWise Diagnostics is headquartered in Tel Aviv, Israel.

When was EyeWise Diagnostics founded?

EyeWise Diagnostics was founded in 2017.

What industry does EyeWise Diagnostics operate in?

EyeWise Diagnostics operates in Healthcare, Optometry, Non-invasive, Examination, HealthTech, MedTech.

How many employees does EyeWise Diagnostics have?

EyeWise Diagnostics has approximately 6 people on record.

What is EyeWise Diagnostics's current status?

EyeWise Diagnostics's current operating status is: Inactive.